Canine mast cell tumours (MCTs) represent one of the most prevalent neoplasms in dogs, characterised by their markedly heterogeneous clinical behaviour. These tumours, ranging from benign lesions ...

ALY-301 is a first-in-class bispecific antibody targeting c-Kit and CD-203c with mast cell selectivity Designed to enable safe dosing in chronic conditions and deliver clinical proof-of concept in a ...

PHOENIX, June 17, 2025 /PRNewswire/ -- Calviri, Inc, a company focused on ending cancer in dogs and people, announces the publication of High-sensitivity multicancer detection of stage 1 cancer in ...